FREDRIC N ESHELMAN Insider Trading $GTHX G1 Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FREDRIC N ESHELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FREDRIC N ESHELMAN. FREDRIC N ESHELMAN is Director in Valeant Pharmaceuticals International, Inc. ($BVF) and CEO in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Chief Executive Officer in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Director in MEDICINES CO /DE ($MDCO) and Executive Chairman in MEDICINES CO /DE ($MDCO) and Director in Aravive, Inc. ($ARAV) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in EYENOVIA, INC. ($EYEN).
FREDRIC N ESHELMAN in G1 Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FREDRIC N ESHELMAN: Director
Holdings: 250,000 shares
Latest Transaction: Jun 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FREDRIC N ESHELMAN in G1 Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, BVF, EYEN, GTHX, MDCO, PPDI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12 2020 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Option Exercise | A | 17.59 | 20,000 | 351,800 | 20,000 | |
| Jun 14 2019 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Option Exercise | A | 18.47 | 20,000 | 369,400 | 20,000 | |
| Jun 11 2018 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Option Exercise | A | 38.39 | 10,000 | 383,900 | 10,000 | |
| Nov 15 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Buy | P | 19.73 | 250,000 | 4,932,500 | 250,000 | 0 to 250 K |
| Jul 13 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Option Exercise | A | 15.55 | 20,000 | 311,000 | 20,000 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Option Exercise | C | 0.00 | 2,524,233 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Option Exercise | C | 0.00 | 6,893,224 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Buy | P | 15.00 | 300,000 | 4,500,000 | 3,439,151 | 3.1 M to 3.4 M (+9.56 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Buy | C | 0.00 | 3,139,151 | 0 | 3,139,151 | 0 to 3.1 M |
Page: 1